etoposide has been researched along with Angiogenesis, Pathologic in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JC; Bendel, AE; Campigotto, F; Chi, SN; Chordas, CA; Comito, MA; Goldman, S; Hubbs, SM; Isakoff, MS; Khatib, ZA; Kieran, MW; Kondrat, L; Manley, PE; Neuberg, DS; Pan, WJ; Pietrantonio, JB; Robison, NJ; Rubin, JB; Turner, CD; Werger, AM; Zimmerman, MA | 1 |
| Fan, D; Hu, Y; Li, S; Xiong, D; Yagüe, E; Yan, C; Yang, M; Zhang, Y; Zhou, Y | 1 |
| DoRosario, A; Kleffel, S; Larson, AR; Lee, N; Lezcano, C; Murphy, GF; Schatton, T; Wang, LC; Zhan, Q | 1 |
| Al-Massarani, G; Alammar, M; Banat, I; Najjar, F | 1 |
| Basha, SA; Bhadra, MP; Bhadra, U; Kamal, A; Kavi Kishor, PB; Lavanya, A; Ramaiah, MJ; Srinivas, C; Yerramsetty, S | 1 |
| Neal, JW; Wakelee, HA | 1 |
| Cheung, K; Coleman, M; Elstrom, R; Faye, A; Furman, RR; Hajjar, KA; Lachs, M; Leonard, JP; Martin, P; Ruan, J | 1 |
| Cawkwell, L; Little, SJ; Maraveyas, A; Murray, A; Stanley, P | 1 |
| Patel, J; Shields, CL; Turaka, K | 1 |
| Daignault, S; Dy, GK; Gadgeel, SM; Kalemkerian, GP; Ramnath, N; Schneider, BJ; Wozniak, AJ | 1 |
| Brown, NJ; Jitlal, M; Lee, SM; Tin, AW; Woll, PJ; Young, RJ | 1 |
| Chyczewska, E; Korniluk, M; Mroz, RM; Ossolinska, M; Panek, B | 1 |
| Belleri, M; Presta, M; Ribatti, D; Vacca, A | 1 |
| Bates, SE; Baumeister, P; Costa, F; Dong, D; Ko, B; Lee, AS; Markland, F; Patterson, JB; Stiles, C; Swenson, S | 1 |
| Leahey, A; Manquez, ME; Meadows, AT; Shields, CL; Shields, JA; Sun, H | 1 |
| Batchelor, TT; Black, PM; Bradshaw, J; Chen-Plotkin, AS; Doherty, L; Drappatz, J; Folkman, J; Gigas, DC; Kesari, S; Kieran, M; Kracher, J; Laforme, A; Levy, B; Muzikansky, A; O'Neill, A; Ramakrishna, N; Schiff, D; Weiss, SE; Wen, PY | 1 |
| Campbell, RB; Dandamudi, S | 1 |
| Gullbo, J; Johnsen, JI; Kogner, P; Larsson, R; Lewensohn, R; Lindskog, M; Lövborg, H; Ponthan, F; Segerström, L; Sveinbjörnsson, B; Viktorsson, K; Wickström, M | 1 |
| Carroll, M; Frankel, P; Ruel, C; Smith-Powell, L; Synold, TW; Twardowski, PW; VanBalgooy, J | 1 |
| Iigo, M; Sagawa, K; Shimamura, M; Tsuda, H | 1 |
| Beinert, T; Binder, D; Fleischhacker, M; Mergenthaler, HG; Oehm, C; Possinger, K; Priem, F; Schweigert, M; Sezer, O; Siebert, G; Stuschke, M; Werner, TG; Ziemer, S | 1 |
| Bello, L; Bikfalvi, A; Black, PM; Carrabba, G; Carroll, RS; Cerutti, F; Giussani, C; Landré, J; Lucini, V; Pluderi, M; Scaglione, F; Tomei, G; Villani, R | 1 |
5 trial(s) available for etoposide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Fenofibrate; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Neovascularization, Pathologic; Prognosis; Prospective Studies; Pyrazoles; Sulfonamides; Survival Rate; Thalidomide; Young Adult | 2014 |
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neovascularization, Pathologic; Prednisone; Procarbazine; Quality of Life; Recurrence; Rituximab; Thalidomide; Treatment Outcome | 2010 |
Phase II trial of sunitinib maintenance therapy after platinum-based chemotherapy in patients with extensive-stage small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Early Termination of Clinical Trials; Etoposide; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Patient Dropouts; Platinum; Pyrroles; Small Cell Lung Carcinoma; Sunitinib; Treatment Outcome | 2011 |
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pyrazoles; Sulfonamides; Thalidomide | 2007 |
Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Celecoxib; Cyclophosphamide; Endothelial Cells; Etoposide; Female; Flow Cytometry; Humans; Male; Middle Aged; Neoplasms; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Pyrazoles; Sensitivity and Specificity; Stem Cells; Sulfonamides | 2008 |
17 other study(ies) available for etoposide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aldehyde Dehydrogenase 1 Family; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Calcium-Binding Proteins; CD24 Antigen; Cell Movement; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Female; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Isoenzymes; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Retinal Dehydrogenase; RNA Interference; RNA, Small Interfering; Spheroids, Cellular; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2014 |
Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Merkel Cell; Cell Line, Tumor; Etoposide; Human Umbilical Vein Endothelial Cells; Humans; Lymph Nodes; Mice, Knockout; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Random Allocation; Skin; Skin Neoplasms; Transplantation, Heterologous | 2014 |
Circulating endothelial cells for evaluation of tumor response in non-small cell lung cancer patients receiving first-line chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Endothelial Cells; Etoposide; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Paclitaxel; Prospective Studies; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2015 |
Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer.
Topics: Apoptosis; Breast Neoplasms; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; MicroRNAs; Models, Molecular; Molecular Docking Simulation; Neovascularization, Pathologic; Podophyllotoxin; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Quinazolines; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2015 |
Elusive Target of Angiogenesis in Small-Cell Lung Cancer.
Topics: Bevacizumab; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neovascularization, Pathologic; Small Cell Lung Carcinoma | 2017 |
Sorafenib enhances the in vitro anti-endothelial effects of low dose (metronomic) chemotherapy.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Administration Schedule; Endothelial Cells; Etoposide; Humans; In Vitro Techniques; Neovascularization, Pathologic; Niacinamide; Paclitaxel; Phenylurea Compounds; Pyridines; Sorafenib; Temozolomide | 2010 |
Resolution of iris neovascularization following chemoreduction of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Iris; Neovascularization, Pathologic; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Ultrasonography; Vincristine; Visual Acuity | 2010 |
Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Deoxycytidine; Etoposide; Female; Fibroblast Growth Factor 2; Gemcitabine; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neovascularization, Pathologic; Proportional Hazards Models; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Survival Analysis; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A | 2012 |
sVEGF R1 and Tie-2 levels during chemotherapy of lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Pulmonary Disease, Chronic Obstructive; Receptor, TIE-2; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-1 | 2013 |
Anti-angiogenic activity of the purine analog 6-thioguanine.
Topics: 2-Aminopurine; Acute Disease; Aged; Allantois; Anemia; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cattle; Cell Line, Transformed; Chick Embryo; Chorion; Cytarabine; Daunorubicin; Drug Evaluation; Endothelial Growth Factors; Endothelium, Vascular; Etoposide; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Humans; Leukemia, Myeloid; Lymphokines; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neovascularization, Pathologic; Neovascularization, Physiologic; Remission Induction; Stress, Mechanical; Thioguanine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Disintegrins; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Etoposide; Female; Glucose; Heat-Shock Proteins; Humans; Mice; Mice, Nude; Molecular Chaperones; Neovascularization, Pathologic; Oxygen; Promoter Regions, Genetic; RNA, Small Interfering; Stilbenes; Transcriptional Activation; Transfection; Xenograft Model Antitumor Assays | 2005 |
Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorescein Angiography; Glaucoma, Neovascular; Humans; Infant; Iris; Neovascularization, Pathologic; Retinal Neoplasms; Retinoblastoma; Vincristine | 2006 |
The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Diffusion; Drug Delivery Systems; Etoposide; Ferrosoferric Oxide; Melanoma; Mice; Neovascularization, Pathologic | 2007 |
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cell Line, Tumor; Cell Survival; Dipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Immunoenzyme Techniques; Male; Melphalan; Mice; Molecular Structure; Neovascularization, Pathologic; Neuroblastoma; Prodrugs; Rats; Rats, Nude; Tumor Cells, Cultured; Vincristine | 2007 |
Characteristics of the inhibitory effect of mitoxantrone and pirarubicin on lung metastases of colon carcinoma 26.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Endothelium, Vascular; Etoposide; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mitoxantrone; Neoplasm Transplantation; Neovascularization, Pathologic; Rats | 1995 |
Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy?
Topics: Adult; Aged; Aged, 80 and over; Albumins; Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Bronchoalveolar Lavage Fluid; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deoxycytidine; Endothelial Growth Factors; Epidermal Growth Factor; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphokines; Male; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Oxidative Stress; Proteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vindesine | 1999 |
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cell Division; Dose-Response Relationship, Drug; Etoposide; Glioblastoma; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neovascularization, Pathologic; Peptide Fragments; Recombinant Proteins; Xenograft Model Antitumor Assays | 2001 |